FLT3 and acute lymphoblastic leukemia: In our investigation of 35 ALL patients with FLT3 gene mutations, we observed that co-mutations associated with diseases primarily affected signaling pathways and transcription factors, accounting for 51.0% and 30.2% of cases, respectively (Figure 2A,C).